Stockreport

Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network

Alimera Sciences, Inc.  (ALIM) 
Last alimera sciences, inc. earnings: 4/29 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alimerasciences.com/investor-relations
PDF ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to [Read more]